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Transitional cell carcinoma (TCC) has been recognized
as one of the main epithelial carcinomas of the ovary.
It is a rare tumor, but its true incidence remains un-
known. It is characterized by its histologic resemblance
to TCC of the bladder. The coincident association of
TCCs of the ovary and the bladder involves two possi-
ble diagnoses: the ovarian TCC could be a primary TCC,
or it could be the result of metastasis of a bladder
TCC. We present a case of TCC of the ovary in a patient
who had previously suffered from high-grade superfi-
cial transitional cell urinary bladder cancer.
A 42-year-old woman was admitted to Ibn-Sina
hospital with hematuria. She underwent transurethral
resection of the bladder (TURB) for diagnostic and
therapeutic purposes. Histopathologic analysis showed
a TCC pT1b G3. Concurrent ultrasound examination
and abdominal computed tomography (CT) showed
no other tumors in the pelvis or abdomen. Further
superficial papillary tumors involving the bladder were
resected at the 24- and 36-month regular follow-ups.
CT scans performed as part of the follow-up proce-
dures failed to detect any other pelvic or abdominal
tumors. TURB was performed on both occasions, but
the patient refused intravesical chemotherapy.
The patient was hospitalized for abdominal pain 
2 months after the last resection (38 months after the
initial resection). Pelvic CT scan revealed an 11.0-cm
cystic mass in the pelvis (Figure 1). The results of bladder
imaging were normal. Laparoscopic resection of the
ovarian tumor was performed, including a left salpingo-
oophorectomy, omentectomy, and sampling of ascites
fluid. The right ovary was macroscopically normal.
Pathologic examination of the monocystic lesion
revealed multiple small papillary formations partly
covering the external and internal surfaces of the cyst.
Microscopic examination showed ovarian tissue infil-
trated by malignant transitional epithelium composed
of blunt papillae lined with stratified epithelium with
solid nests. Periodic acid-Schiff-positive microcystic
spaces were also identified (Figure 2). The cells had
round or ovoid nuclei, with nucleoli or longitudinal
grooves, and frequent mitosis. The tumor was exten-
sively sampled, and no components of other ovarian
epithelial tumors, such as serous or endometrioid ade-
nocarcinomas, were found. The presence of a benign or
borderline Brenner component was also excluded. The
omentum was free of tumor and the cytology of the
ascites fluid was negative for malignant cells. This ovarian
tumor was indistinguishable from the previous TCC of
the bladder, and was initially diagnosed as an ovarian
metastasis from the urinary bladder carcinoma. Indeed,
the TURB examination performed at 36 months demon-
strated the same features, with papillary structures lined
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Figure 1. Pelvic computed tomography scan shows an 11.0-cm
cystic mass of the pelvis.
by transitional cells and mucus-containing microcysts
(Figure 2).
Specimens from the bladder and ovary were stained
with monoclonal antibodies for CK7, CK20, and CA125.
Both tumors were diffusely and homogeneously posi-
tive for CK7. However, the bladder TCC showed focal
and heterogeneous CK20 expression, while the ovarian
tumor was negative for CK20. The Mullerian marker
CA125 was strongly expressed in the ovarian cells, while
this marker was negative in the bladder TCC (Figure 3).
The immunohistochemical results are summarized in
the Table. These data support the diagnosis of a pri-
mary ovarian tumor. Additional laparotomy to com-
plete surgical resection and adjuvant chemotherapy
were planned.
TCC of the ovary is a subtype of ovarian carci-
noma, characterized by a histologic resemblance to
TCC of the bladder [1]. The World Health Organization
classification defines ovarian TCC as a carcinoma that
presents with morphologic urothelial features but, in
contrast to malignant Brenner tumor, lacks the elements
of benign or borderline Brenner tumors. It is characterized
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Figure 2. (A) Low-power view of the ovary tumor showing blunt papillae lined by multilayered epithelium (hematoxylin and eosin
[HE]; original magnification, ×40). (B) Low-power view of the 36-month follow-up transurethral bladder biopsy showing the
same pattern (HE, ×40). (C) Solid neoplastic nests invading the ovarian stroma (HE, ×200). (D) High-power view showing the
ovarian tumor cells with round or ovoid nuclei, nucleoli, longitudinal grooves, and frequent mitosis (HE, ×400). Microcysts of
varying sizes, strongly Periodic acid-Schiff-positive in the (E) ovarian tumour, and (F) bladder transitional cell carcinoma.
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Figure 3. Immunohistochemical staining. CK7 expressed in a diffuse membrane pattern in both (A) ovarian and (B) bladder
tumors (original magnification, ×200). (D) CK20 was focally expressed in a heterogeneous membrane pattern in the bladder
transitional cell carcinoma (original magnification, ×400), but not in the ovary transitional cell carcinoma (C; original magni-
fication, ×200). (E) CA125 was strongly and heterogeneously expressed in the ovarian proliferation, (F) but not in the bladder
(original magnification, ×40).
Table. Summary of immunohistochemical results
Markers Source Clone Dilution Ovarian tumor Bladder tumor
CK7 DAKO OV-TL 12/30 1:30 Positive Positive 
(membranous pattern) (membranous pattern)
CK20 DAKO Ks20.8 1:300 Negative Focal and heterogeneous 
positivity (membranous pattern)
CA125 Immunotech, OC125 Prediluted Positive Negative
Westbrook, ME preparation
by the presence of papillae lined by malignant cells of
transitional cell type, and sometimes by mucin-producing
glands [1,2]. This neoplasm can occur in a pure form,
but is frequently associated with other cell types (serous,
endometrioid, or undifferentiated components) [3].
In the current case, the ovarian tumor was morpho-
logically similar to urinary bladder TCC, showing the
same structural features as papillae and microcysts
filled with periodic acid-Schiff-positive mucus. The lack
of benign or borderline Brenner elements and the absence
of other cell types of ovarian origin (serous or endo-
metrioid zones), suggested the possibility of a rare pri-
mary ovarian tumor, in contrast to a metastatic lesion
derived from the bladder TCC [4]. Conventional histo-
logic staining was unable to clarify the tumor origin.
Immunohistochemistry may be helpful for distin-
guishing TCC of the ovary from TCCs of urothelial 
origin. CK20 represents a useful marker for differentiat-
ing between these two entities, because it is commonly
expressed in bladder TCC, but is negative in TCC of
the ovary [5–8]. Additionally, the Mullerian marker
CA125 is often strongly expressed in ovarian tumors,
but is absent from bladder TCC. Some authors [5–8]
have reported that the immunophenotype of ovarian
TCC closely resembles that of ovarian surface epithe-
lial-stromal tumors. This profile differs from that of
bladder TCC, despite the morphologic similarities.
These findings are in accord with the results of a study
indicating that the genetic mutation patterns in ovar-
ian TCC differ from those found in bladder TCC [9].
In the current case, the expression of CA125 and
lack of expression of CK20 supported the hypothesis
of primary ovarian differentiation, favoring indepen-
dent origins for the two tumors, rather than ovarian
metastasis of the bladder TCC. TCCs of the bladder and
ovary have different treatments and prognoses, and it
is therefore important to distinguish between these two
lesions in terms of diagnostic tests and treatments.
This case emphasizes the difficulties associated with
relying on morphologic analysis alone to distinguish
between a primary origin for TCC of the ovary, and its
metastatic derivation from a bladder TCC. We there-
fore conclude that immunohistochemistry should be
performed in cases of coincident ovary and bladder
carcinomas with transitional cell histologies.
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